RE Champlin
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation 27
- Chronic Myeloid Leukemia Treatments 9
- Acute Myeloid Leukemia Research 5
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 7
- Immunology top 5%
- Transplantation top 5%
- Oncology top 2%
- Polyomavirus and related diseases 6
- Neutropenia and Cancer Infections 6
-
- Acute Lymphoblastic Leukemia research 7
-
- Transplantation: Methods and Outcomes 7
- Cited by
- HematologyGeneticsImmunology
- Journals
- Blood (28 papers)Bone Marrow Transplantation (12 papers)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
RE Champlin
50 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 2.7k
- Genetics 869
- Immunology 912
- Transplantation 115
- Oncology 1.0k
Countries citing papers authored by RE Champlin
This map shows the geographic impact of RE Champlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RE Champlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RE Champlin more than expected).
Fields of papers citing papers by RE Champlin
This network shows the impact of papers produced by RE Champlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RE Champlin. The network helps show where RE Champlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside RE Champlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 20 | |
| 2 | 2004 | 12 | |
| 3 | Addition of antithymocyte globulin (ATG) to cyclophosphamide (Cy) for HLA-identical sibling allogeneic bone marrow transplantation (BMT) for severe aplastic anemia (SAA) : results of a randomized controlled trial | 2003 | 3 |
| 4 | 2002 | 40 | |
| 5 | 2002 | 17 | |
| 6 | 2001 | 77 | |
| 7 | 2001 | 97 | |
| 8 | 2000 | 34 | |
| 9 | 2000 | 17 | |
| 10 | 2000 | 66 | |
| 11 | 1999 | 24 | |
| 12 | 1999 | 9 | |
| 13 | 1997 | 175 | |
| 14 | 1995 | 4 | |
| 15 | 1995 | 10 | |
| 16 | 1994 | 1 | |
| 17 | 1993 | 16 | |
| 18 | 1992 | 43 | |
| 19 | 1985 | 158 | |
| 20 | 1985 | 87 |
About RE Champlin
RE Champlin is a scholar working on Hematology, Transplantation, Genetics, Oncology and Immunology, having authored 50 papers that have together received 3.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (27 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Transplantation: Methods and Outcomes (7 papers), Polyomavirus and related diseases (6 papers), Neutropenia and Cancer Infections (6 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Hematology (2.7k citations), Genetics (869 citations), Immunology (912 citations), Transplantation (115 citations) and Oncology (1.0k citations). RE Champlin has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include DW Golde, Gale Rp, MM Horowitz, DW van Bekkum, Good Ra, RC Ash, A Marmont, BM Camitta, Éliane Gluckman and Dicke Ka. Their work appears in journals such as Blood, Bone Marrow Transplantation, Annals of the Rheumatic Diseases, Clinical Pharmacology & Therapeutics and Radiation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.